The MHRA have issued updated advice on non-prescription medicines containing codeine or dihydrocodeine (DHC). This affects all OTC solid dose medicines containing codeine or DHC. The MHRA states that changes to the marketing authorisations need to take place by 31 December 2009, and that packs with the new information should be available within 3-6 months.
Further information can be found on the MHRA website.